1-14 of 14
Wei-Ying Jen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of a Novel Artificial Intelligence Tool to Measure Psoas Volumes in Patients with Diffuse Large B Cell Lymphoma

Edwin Wei Sheng Thong, Andrew Makmur, Yen-Lin Chee, James Hallihan, Lenith Tai Jit Cheng, Nesaretnam Barr Kumarakulasinghe, Anand Devaprasath Jeyasekharan, Joanne Shu Xian Lee, Sanjay De Mel, Esther Hian Li Chan, Michelle Poon, Wee-Joo Chng, Jayalakshmi ., Melati Dewi Ali, Wei-Ying Jen, Desmond Shi Wei Lim
Journal: Blood
Blood (2023) 142 (Supplement 1): 3652.
https://doi.org/10.1182/blood-2023-178239
Published: 2023
Journal Articles

Phase 2 Trial of Mini-Hyper-CVD Plus Inotuzumab Ozogamicin, with or without Blinatumomab, in Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia

Wei-Ying Jen, Elias Jabbour, Fadi G. Haddad, Nicholas J. Short, Nitin Jain, Tapan M. Kadia, Naval Daver, Gautam Borthakur, Lewis Nasr, Courtney D. DiNardo, Marianne Zoghbi, Jovitta Jacob, Edith Roy, Christopher Loiselle, Anna Milton, Juan Rivera, Rebecca Garris, Farhad Ravandi, Hagop M. Kantarjian
Journal: Blood
Blood (2023) 142 (Supplement 1): 2878.
https://doi.org/10.1182/blood-2023-182982
Published: 2023
Journal Articles

A Phase 2 Study of Daratumumab in Combination with Thalidomide and Dexamethasone in Relapsed and / or Refractory Myeloma: A Report from the Asian Myeloma Network

Wei-Ying Jen, Melissa Ooi, Sanjay De Mel, Cinnie Soekojo, Sung-Soo Yoon, Xinhua Li, Neha Awasthi, Sarah M Burkill, Brian GM Durie, Wee-Joo Chng
Journal: Blood
Blood (2023) 142 (Supplement 1): 2009.
https://doi.org/10.1182/blood-2023-180017
Published: 2023
Journal Articles

Clinical Evaluation of a Functional Combinatorial Precision Medicine Platform to Predict Patient-Specific Treatment Outcomes in Acute Myeloid Leukemia

Edward Chow, Noor Rashidha Binte Meera Sahib, Masturah Rashid, Jhin Jieh Lim, Wei-Ying Jen, Melissa Ooi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2276.
https://doi.org/10.1182/blood-2023-186251
Published: 2023
Journal Articles

Feasibility and Implementation of an out-of-Pocket Cost Calculator for Pre-Treatment Financial Counselling in Cancer Patients

Maggie Wong, Zhi Yao Chan, Mei Yin Quek, Alexis Koh, Constance Teo, Jinny Foo, Cheng Ean Chee, Andrea Wong, Samuel Ow, Joey Tay, Vivian Luah, Xiao Shi Saw, Yuet Peng Wong, Meng Tuck Lee, Jolene Lee, Chee-Yen Lin, Wei-Ying Jen, Wee-Joo Chng, Janelle Chua
Journal: Blood
Blood (2023) 142 (Supplement 1): 3728.
https://doi.org/10.1182/blood-2023-184753
Published: 2023
Journal Articles

Phase 2 Study of CPX-351 in Combination with Venetoclax in Patients with Newly Diagnosed, High Risk Acute Myeloid Leukemia

Wei-Ying Jen, Courtney D. DiNardo, Kelly S. Chien, Yesid Alvarado-Valero, Lucia Masarova, Mark Brandt, Debra Bull-Linderman, Naval Daver, Guillermo Montalban-Bravo, Alex Bataller, Guillermo Garcia-Manero, Ghayas C. Issa, Amin Alousi, Nicholas J. Short, Farhad Ravandi, Tapan M. Kadia
Journal: Blood
Blood (2023) 142 (Supplement 1): 4273.
https://doi.org/10.1182/blood-2023-182969
Published: 2023
Journal Articles

A Phase II Study of Low-Intensity Chemotherapy (Mini-Hyper-CVD) and Ponatinib Followed By Blinatumomab and Ponatinib in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Wei-Ying Jen, Elias Jabbour, Fadi G. Haddad, Lewis Nasr, Nicholas J. Short, Marianne Zoghbi, Cedric Nasnas, Ghayas C. Issa, Musa Yilmaz, Naval Daver, Naveen Pemmaraju, Lucia Masarova, Farhad Ravandi, Nitin Jain, Wuliamatu Deen, Christopher Loiselle, Lourdes Waller, Glenda Banks, Rebecca Garris, Hagop M. Kantarjian
Journal: Blood
Blood (2023) 142 (Supplement 1): 2868.
https://doi.org/10.1182/blood-2023-182997
Published: 2023
Journal Articles

Survival Outcomes, Efficacy and Tolerability of a Pediatric-Inspired Regimen (MASPORE) for Philadelphia-Negative Acute Lymphoblastic Leukemia in Young Adults at a Tertiary Hospital in Singapore

Victor Ling Wei Teik, Sai Lon Wann, Jing Yuan Tan, Jameelah Sheik Mohamed, Wei Ying Jen, Pak Ling Lui, Michelle Poon, Esther Hian Li Chan, Liang Piu Koh, Lip Kun Tan, Chin Hin Ng, Allen Eng Juh Yeoh, Melissa Ooi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5881.
https://doi.org/10.1182/blood-2023-189139
Published: 2023
Journal Articles

Randomized Phase 3 Study of Pomalidomide Cyclophosphamide Dexamethasone (PCD) Versus Pomalidomide Dexamethasone (PD) in Relapse or Refractory Myeloma: An Asian Myeloma Network (AMN) Study

Yang Song, Jin Seok Kim, CS Chim, Je-Jung Lee, Sung-Soo Yoon, Soo Chin Ng, Gin Gin Gan, Hiroshi Handa, Wei-Ying Jen, Xinhua Li, Yogesh Mahadev Pokharkar, Brian GM Durie, Wee-Joo Chng
Journal: Blood
Blood (2023) 142 (Supplement 1): 1009.
https://doi.org/10.1182/blood-2023-184723
Published: 2023
Journal Articles

Mitochondrial Functional Profiling Links Apoptotic Sensitivity to Treatment Outcomes Based on Age and Cell Lineage in Acute Leukemia

Prasad Ramanakrishnan Iyer, Shaista Shabbir Jasdanwala, Jameelah Binte Sekh Mohamed, Si Ting Tai, Wei-Ying Jen, Melissa Ooi, Allen Eng Juh Yeoh, Shruti Bhatt
Journal: Blood
Blood (2023) 142 (Supplement 1): 5966.
https://doi.org/10.1182/blood-2023-188541
Published: 2023
Journal Articles

Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis

Mingrui Guo, Tim Hon Man Chan, Qiling Zhou, Omer An, Ying Li, Yangyang Song, Zi Hui Tan, Vanessa Hui En Ng, Philomina Sona Peramangalam, Zhi Qing Tan, Xinang Cao, Eisaku Iwanaga, Masao Matsuoka, Melissa G. M. Ooi, Wei Ying Jen, Liang Piu Koh, Esther Chan, Lip Kun Tan, Yufen Goh, Wilson Wang, Bryan T. H. Koh, Chan Ming Chun, Melissa J. Fullwood, Wee Joo Chng, Motomi Osato, John Anto Pulikkan, Henry Yang, Leilei Chen, Daniel G. Tenen
Journal: Blood
Blood (2023) 141 (25): 3078–3090.
https://doi.org/10.1182/blood.2022015830
Published: 2023
Includes: Supplemental data
Journal Articles

Reducing Time to Chemotherapy Administration in the Outpatient Setting of a Tertiary Cancer Centre Using a Design Thinking Approach

Wei-Ying Jen, BM BCh, FRCPath, Zhi Yao Chan, MSc (Clin Pharm), Mary Chong, BN, Mariana Ibrahim, BSN, Melinda Khoo, BSc (Hons), Judith Lee, BN, MSOL, Meng Tuck Lee, Dipl.-Ing. Univ., Yee Mei Lee, BSN, MN, PhD, Siew Woon Lim, MSc (Clin Pharm), Noel Ng, BBus(Mgt), Ednajoy Ngo, BHSN, MN, Belinda Tan, BHSN, GradDipNsg(Onc), Rui Xian Tay, MBA, Constance Teo, MSc (Clin Pharm), Yuet Peng Wong, MSc (Clin Pharm), Cheng Ean Chee, MBBS, ABIM (MDOnc), ABIM (Heme), FCAP, Yen-Lin Chee, MB ChB, FRCPath, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 18–20.
https://doi.org/10.1182/blood-2020-138603
Published: 2020
Journal Articles

Maximising Capacity and Saving Cost in an Outpatient Chemotherapy Centre during a Pandemic: A Quality Improvement Project

Ednajoy Ngo, Cheng Ean Chee, MBBS, ABIM (MDOnc), ABIM (Heme), FCAP, Melinda Khoo, BSc (Hons), Yee Mei Lee, BSN, MN, PhD, Belinda Tan, BHSN, GradDipNsg(Onc), Yen-Lin Chee, MBChB, FRCPath, PhD, Wei-Ying Jen, MA,FRCPath,MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 25–26.
https://doi.org/10.1182/blood-2020-139138
Published: 2020
Journal Articles

Single Institution Phase 1 Study on Combination Therapy of Midostaurin and Panobinostat in Acute Myeloid Leukemia - the Interim Report

Chin-Hin NG, MD MRCP, FRPATH, Liang Piu Koh, MBBS, MRCP, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Wei Ying Jen, MA, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 5237.
https://doi.org/10.1182/blood-2018-99-120327
Published: 2018